Fresenius SE & Co. KGaA is a DAX 40 German healthcare group (ETR:FRE) headquartered in Bad Homburg vor der Höhe with roughly 191,000 employees and approximately EUR 21 billion of annual continuing-operations revenue, controlled by the Else Kröner-Fresenius-Stiftung charitable foundation.
The group operates two focus businesses in 2026: Fresenius Kabi (IV drugs, clinical nutrition, biosimilars, plasma-derived therapeutics, specialty medical devices) and Fresenius Helios (approximately 87 German hospitals under Helios Kliniken plus approximately 57 Spanish hospitals and a large outpatient footprint under Quirónsalud). Fresenius Medical Care was reclassified to equity-method accounting in 2023 and Fresenius Vamed has been substantially wound down under the Fresenius 2025 simplification programme.
You're here early and that means a lot! ResumeGeni is in Beta which means it isn't 100% finished yet, but every day I'm working towards the vision. It's my goal to help you land your next job.
During the Beta, you'll get access to the state of the art AI to help find your perfect match, and when you do ResumeGeni will prepare your resume to get you to the interview.
There's still a lot to do. Please reach out if you have feedback, a request, or just want to send me a note.